Acquiring Company
Eli Lilly and Company
Acquired Company
Ajax Therapeutics, Inc.
IndianapolisNew YorkManufacturingBiotechnologyHealth CareMedicalPharmaceuticalOtherBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Eli Lilly is acquiring Ajax Therapeutics for up to $2.3 billion, marking its third oncology deal in three weeks. This acquisition focuses on Ajax's lead program AJ1-11095, a promising treatment for rare blood cancers. The deal will enhance Lilly's portfolio in hematology and oncology, expanding its presence in blood-based cancers. The acquisition includes milestone payments alongside an undisclosed upfront payment.
Quick answer
Eli Lilly and Company is acquiring Ajax Therapeutics, Inc. for $2.3 billion, announced April 27, 2026. Eli Lilly and Company is based in Indianapolis, Indiana, United States.
- Who acquired Ajax Therapeutics, Inc?
- Eli Lilly and Company agreed to acquire Ajax Therapeutics, Inc. on April 27, 2026.
- How much did Eli Lilly and Company pay for Ajax Therapeutics, Inc?
- The reported deal value is $2.3 billion.
- What does Eli Lilly and Company do?
- Lilly is a medicine company turning science into healing to make life better for people around the world.
- Where are Eli Lilly and Company and Ajax Therapeutics, Inc. based?
- Eli Lilly and Company is based in Indianapolis, Indiana, United States. Ajax Therapeutics, Inc. is based in New York, New York, United States.
- Who are the decision-makers at Eli Lilly and Company?
- Fundz holds 5 contacts at Eli Lilly and Company. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Eli Lilly to acquire Centessa Pharmaceuticals (March 31, 2026)
- Galmed Pharmaceuticals to acquire Colospan for GI focus (June 8, 2026)
- Aurinia acquires Kezar Life Sciences for $6.955/share (March 30, 2026)
- GSK to acquire Nuvalent for $10.6 billion, $11B (June 9, 2026)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ajax Therapeutics, Inc.?
Ajax Therapeutics, Inc. was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on April 27, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire Ajax Therapeutics, Inc.?
Eli Lilly and Company's acquisition of Ajax Therapeutics, Inc. was reported on April 27, 2026. Eli Lilly is acquiring Ajax Therapeutics for up to $2.3 billion, marking its third oncology deal in three weeks. This acquisition focuses on Ajax's lead program AJ1-11095, a promising treatment for rare blood cancers. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ajax Therapeutics, Inc. do?
Ajax Therapeutics, Inc. is pursuing uniquely selective approaches to develop novel next generation therapies for myeloproliferative neoplasms (MPNs), including myelofibrosis. It is privately held, operating in Other, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.